Skip to content

Clinical trials

Withdrawn Scleroderma, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Withdrawn Country / region: China Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Boren Hospital1
Nanjing Legend Biotech Co.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic2
Myositis2
Scleroderma, Systemic2
Anemia, Hemolytic, Autoimmune1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Autoimmune Diseases1
Multiple Sclerosis1
Recurrence1
Sjogren's Syndrome1

Trials

Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.